Vericel (NSDQ:VCEL) is growing skin grafts using its Epicel product to help a baby born in Texas without skin, according to a recent Boston Business Journal report. The company said yesterday that it is creating grafts with its Epicel skin replacement product for newborn Ja’bari Gray, who has been in intensive care since being born earlier […]
Wound Care
Tikehau Capital puts $29m into UK-based Medtrade
Tikehau Capital said yesterday that it invested approximately $29.1 million (EU €26 million) into UK-based medical device firm Medtrade Products. Medtrade produces advanced wound care and consumer healthcare products including the Celox trauma hemostat and Foxseal occlusive dressing, according to its website. “We are delighted to be partnering with Tikehau Capital on this next and […]
Organogenesis boosts revenue, cuts losses in Q1
Organogenesis (NSDQ:ORGO) posted a smaller loss year-over-year during its first quarter, and boosted its outlook for the rest of the year amid strong sales growth in its wound-care business. The Canton, Mass.–based regenerative medicine company reported a loss of $15.7 million, or 17 cents per share, on sales of $57.1 million for the three months […]
Vericel inks licensing deal for MediWound’s NexoBrid, posts Q1 earnings
Vericel (NSDQ:VCEL) said yesterday it inked an exclusive U.S. licensing and supply agreement with MediWound (NSDQ:MDWD) for its NexoBrid biological product, and reported first quarter earnings that missed expectations on Wall Street. The NexoBrid is a topically-administered product intended to enzymatically remove nonviable burn tissue in patients with deep partial and full-thickness thermal burns. The product has […]
Misonix puts up $97m in stock for Solsys Medical
Misonix (NSDQ:MSON) said yesterday that it put $97 million in stock on the table for Solsys Medical, formerly Soluble Systems, and its TheraSkin regenerative wound dressing. The deal calls for Farmingdale, N.Y.-based Misonix to issue 5.7 million new shares to Solsys stockholders, which would leave MSON investors owning 64% of the new company and former Solsys […]
Smith & Nephew gains on raised outlook
Smith & Nephew (NYSE:SNN) shares gained in London and New York today after the medical device giant met the consensus forecast for its first-quarter sales and raised its top-line outlook on the rest of the year. The London-based wound care and orthopedics company reported sales growth of 0.5% to $1.20 billion, in line with the […]
3M to pay $6.7B for Acelity
3M (NYSE:MMM) said today that it agreed to pay more than $6.7 billion to acquire wound care giant Acelity, including its debts, from the private equity consortium that took KCI private for $6.3 billion back in 2011. San Antonio, Texas-based Acelity, which registered for an initial public offering last month, was formed after Apax Partners and […]
Sotera Medical, OrthoHelix founders partner to form Okapi Medical
Sotera Medical co-founder Bill Fuller and OrthoHelix founder Dr. David Kay are teaming up to form a new medical device company, dubbed Okapi Medical, according to a recent Crain’s Cleveland report. The newly founded Akron, Ohio-based business aims to develop a new type of bandage using technology from University of Akron polymer researchers to enable […]
Acelity registers for another IPO
Wound care and regenerative medicine company Acelity said today that it filed a registration statement with the SEC for another attempt at an initial public offering. The registration comes on the heels of a failed attempt at an IPO, launched in August of 2015, in which the company looked to fetch up to $1 billion. […]
Avita says EU sales temporarily interrupted, inks Japanese distro deal for Recell
Avita Medical (ASX:AVH) said yesterday that sales of its Recell device in the European Union were temporarily interrupted due to an administrative issue with its notified body and announced a new Japanese marketing and distribution deal. The Valencia, Calif.-based company said that the sales interruption occurred after its EU-based notified body “reported open items related to […]
Acelity’s KCI launches Abthera NPWT system in Japan
Acelity subsidiary KCI said today that it launched its Abthera open abdomen negative pressure therapy system in Japan. The San Antonio-based company’s Abthera is a temporary abdominal closure system intended to allow surgeons to manage challenging abdominal wall openings where primary closure is not possible and to manage repeat abdominal entries. KCI said that the system has […]